The Maternal Fetal Medicine-Units Network (MFMU) antenatal vaginal birth after cesarean (VBAC) prediction model has been used to aid clinicians in counseling patients but labor management has changed since its development. Secondary to the model's suboptimal performance in our population, we aimed to identify factors predictive of success in the contemporary era of labor management. STUDY DESIGN: This is a retrospective cohort study of all women with one prior low transverse cesarean who underwent a trial of labor (TOLAC) at term with a non-anomalous singleton gestation between January 2011 and May 2018 at out academic tertiary care center. Regression analysis incorporated clinical factors available early in pregnancy. Data regarding antepartum factors that may influence TOLAC success and maternal and neonatal outcomes was also extracted from medical records for evaluation (Table 1) . A receiver operating characteristic curve for our model was compared to the MFMU model to compare their performance. RESULTS: Of 1307 VBAC attempts, 1042 pregnancies met inclusion criteria with all of the variables necessary for calculation of predicted VBAC success using the MFMU model. The derived model includes seven antenatal factors: age, race, height, intake weight, number of prior vaginal deliveries, pregestational diabetes, and history of tobacco use ( Table 2 ). The median predicted VBAC success rate was 76.6 % (IQR 64.8, 86.3) while the observed success rate was 74.2 % (difference 2.4 %, 95% CI -1.3-6.1 %). The median predicted probability of success was significantly higher for women who had a successful TOLAC (median 79.6 % (IQR 68.6, 88.1) than for those who had a repeat cesarean (66.1 % (IQR 54.8, 77.9, P < .0001). Area under the curve (AUC) for the model is 0.72 (95% confidence interval (CI) 0.68-0.75) which indicates better performance compared to the MFMU antenatal model which had a AUC of 0.69 (95% CI 0.65 e 0.72, P <.01). CONCLUSION: VBAC success is correlated with seven readily attainable antenatal clinical factors that, along with the predictive model that incorporates them warrant further investigation as they may improve our ability to predict VBAC success and counseling in the contemporary era of labor management.
OBJECTIVE:
The Maternal Fetal Medicine-Units Network (MFMU) antenatal vaginal birth after cesarean (VBAC) prediction model has been used to aid clinicians in counseling patients but labor management has changed since its development. Secondary to the model's suboptimal performance in our population, we aimed to identify factors predictive of success in the contemporary era of labor management. STUDY DESIGN: This is a retrospective cohort study of all women with one prior low transverse cesarean who underwent a trial of labor (TOLAC) at term with a non-anomalous singleton gestation between January 2011 and May 2018 at out academic tertiary care center. Regression analysis incorporated clinical factors available early in pregnancy. Data regarding antepartum factors that may influence TOLAC success and maternal and neonatal outcomes was also extracted from medical records for evaluation (Table 1) . A receiver operating characteristic curve for our model was compared to the MFMU model to compare their performance. RESULTS: Of 1307 VBAC attempts, 1042 pregnancies met inclusion criteria with all of the variables necessary for calculation of predicted VBAC success using the MFMU model. The derived model includes seven antenatal factors: age, race, height, intake weight, number of prior vaginal deliveries, pregestational diabetes, and history of tobacco use ( Table 2 ). The median predicted VBAC success rate was 76.6 % (IQR 64.8, 86. 3) while the observed success rate was 74.2 % (difference 2.4 %, 95% CI -1.3-6.1 %). The median predicted probability of success was significantly higher for women who had a successful TOLAC (median 79.6 % (IQR 68.6, 88.1) than for those who had a repeat cesarean (66.1 % (IQR 54.8, 77.9, P < .0001). Area under the curve (AUC) for the model is 0.72 (95% confidence interval (CI) 0.68-0.75) which indicates better performance compared to the MFMU antenatal model which had a AUC of 0.69 (95% CI 0.65 e 0.72, P <.01). CONCLUSION: VBAC success is correlated with seven readily attainable antenatal clinical factors that, along with the predictive model that incorporates them warrant further investigation as they may improve our ability to predict VBAC success and counseling in the contemporary era of labor management.
811 Delineation of risks associated with specific pre-pregnancy BMI classes OBJECTIVE: Studies supporting the association of increased maternal body mass index (BMI) and adverse pregnancy outcomes fail to quantify risks of individual BMI classes. The purposes of this study were to assess for significant trends as BMI increased and to examine associations between each pre-pregnancy BMI class and obstetric complications. STUDY DESIGN: This IRB-approved retrospective cohort study analyzed pregnant women ages 18-50 years with singleton gestations and available pre-pregnancy BMI who delivered at Geisinger from 1/ 1/2004-12/31/2017. We excluded pregnancies complicated by multifetal gestations, chronic hypertension, or preexisting diabetes mellitus. Patients were stratified by pre-pregnancy BMI according to World Health Organization classifications. Maternal outcomes included gestational hypertension (GHTN), preeclampsia, gestational diabetes mellitus (GDM), preterm delivery (PTD), preterm pre-labor rupture of membranes (PPROM), induction of labor (IOL), mode of delivery, estimated blood loss (EBL), and operative time. Neonatal outcomes included birthweight (BW), hypoglycemia and neonatal intensive care unit (NICU) admission. Logistic regression was used to compare groups and to calculate the test of trend for binary outcomes. ANOVA was used for continuous outcomes. RESULTS: A total of 27,523 women were included for maternal outcomes. Of these, 945 (3.4%) were underweight (UW), 11,328 (41.2%) normal weight (NW), 6797 (24.7%) overweight (OW), 4271 (15.5%) Class I, 2418 (8.8%) class II, and 1764 (6.4%) class III. There were 26,648 pregnancy episodes with neonatal data linked to maternal: these were used for neonatal outcomes. We adjusted for age, race, parity, and tobacco use: GHTN, preeclampsia, GDM, IOL, vaginal delivery, EBL, operative time, neonatal BW, hypoglycemia and NICU admission significantly increased as BMI increased (Table). UW women had higher PTD, PPROM, EBL, NICU admissions, and lower neonatal BW when compared to NW women. OW and all obesity classes had higher rates of GHTN, preeclampsia, GDM, IOL, vaginal delivery, vaginal delivery, EBL, longer operative time, and higher neonatal BW when compared to NW. CONCLUSION: Our results provide specific delineation of risks associated with specific pre-pregnancy BMI classes. GHTN, preeclampsia, GDM, vaginal delivery, EBL, and operative time increase as BMI class increases. Neonatal BW, hypoglycemia and NICU admissions also increase as BMI class increases.
812 Hemoglobin A1C: an independent predictor of large-for-gestational age infants 
To evaluate the rate of large-for-gestational age infants delivered by women with an early normal versus pre-diabetic range hemoglobin A 1C . STUDY DESIGN: We performed a retrospective cohort study of singleton, non-anomalous pregnancies comparing the rates of largefor-gestational age (LGA) infants to women with an early hemoglobin A 1C (HbA 1C ; drawn <20 weeks gestation) of <5.7% (normal) to 5.7-6.4% (pre-diabetes) who delivered at Oregon Health & Science University from 2012-2014. Chi squared analysis was performed to compare rates of LGA, shoulder dystocia, gestational diabetes, preeclampsia, and cesarean delivery in women with a normal HbA1C (<5.7%) versus pre-diabetic HbA1C (5.7-6.4%). Multivariate logistic regression was used to determine the strength of association between LGA infants and HbA 1C , adjusting for body mass index, maternal weight gain, gestational diabetes, preeclampsia, chronic hypertension and tobacco use. RESULTS: Of the 643 patients in whom HbA 1C was obtained <20 weeks gestation, women with HbA 1C in the pre-diabetes range had significantly higher rates of LGA infants (21.7 vs 10.2%; p<0.001), gestational diabetes (GDM; 59.4 vs 20.8%, p< 0.001), and shoulder dystocia (4.5 vs 1.7%, p<0.050) compared to women with normalrange HbA 1C . HbA 1C in the pre-diabetic range was significantly associated with a 70% increased risk of LGA (OR 2.4 [95% CI 1.4-4.2]) that remained statistically significant after adjusting for relevant confounders (aOR 2.04 [95% CI 1.11-3.73]) including GDM. Incidence of cesarean delivery and preeclampsia were not significantly different between groups. CONCLUSION: Maternal HbA 1C of 5.7-6.4% <20 weeks gestation is associated with an increase in LGA infants independent of recognized risk factors for LGA such as obesity and GDM. Our data suggests that an elevated HbA 1C prior to 20 weeks gestation may be a marker for dysmetabolism, beyond insulin resistance. Future studies to further characterize and develop early interventions to reduce rates of LGA in this population are necessary to improve perinatal outcomes.
